Bank of New York Mellon
EVLO

Bank of New York Mellon’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bank of New York Mellon’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-658
Closed -$2.38K – 4496
2023
Q1 		$2.38K Hold
658
– – ﹤0.01% 4383
2022
Q4 		$21.2K Hold
658
– – ﹤0.01% 4348
2022
Q3 		$27K Hold
658
– – ﹤0.01% 4412
2022
Q2 		$28K Sell
658
-3,894
-86% -$181K ﹤0.01% 4458
2022
Q1 		$309K Sell
4,552
-83
-2% -$6.91K ﹤0.01% 4000
2021
Q4 		$563K Buy
4,635
+85
+2% +$14.4K ﹤0.01% 3733
2021
Q3 		$640K Buy
4,550
+766
+20% +$152K ﹤0.01% 3660
2021
Q2 		$1.04M Buy
3,784
+1,011
+36% +$255K ﹤0.01% 3393
2021
Q1 		$594K Sell
2,773
-149
-5% -$41.2K ﹤0.01% 3597
2020
Q4 		$707K Buy
2,922
+1,243
+74% +$154K ﹤0.01% 3449
2020
Q3 		$177K Buy
1,679
+86
+5% +$7.83K ﹤0.01% 3873
2020
Q2 		$156K Sell
1,593
-474
-23% -$41.5K ﹤0.01% 3853
2020
Q1 		$156K Hold
2,067
– – ﹤0.01% 3799
2019
Q4 		$168K Hold
2,067
– – ﹤0.01% 3952
2019
Q3 		$252K Sell
2,067
-113
-5% -$15.5K ﹤0.01% 3839
2019
Q2 		$392K Buy
2,180
+583
+37% +$94.3K ﹤0.01% 3715
2019
Q1 		$255K Sell
1,597
-247
-13% -$48.9K ﹤0.01% 3797
2018
Q4 		$480K Buy
1,844
+1,099
+148% +$221K ﹤0.01% 3509
2018
Q3 		$181K Buy
745
+49
+7% +$12.8K ﹤0.01% 3959
2018
Q2 		$165K Buy
+696
New +$203K ﹤0.01% 3939

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon's EVLO Position: Q2 2023 in Review

Bank of New York Mellon sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2023, closing a stake of 658 shares — an estimated $2.38K sold.

Bank of New York Mellon first reported a position in EVLO in Q2 2018 and held it in 20 quarters. The position peaked at $1.04M in Q2 2021. 25 funds tracked by Wall St. Rank hold EVLO as of Q2 2023.

  • Bank of New York Mellon reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 658 Evelo Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $2.38K.
  • Bank of New York Mellon first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 20 quarters.
  • Bank of New York Mellon's Evelo Biosciences, Inc. Common Stock position peaked at $1.04M in Q2 2021.
  • 25 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2023.

Based on Bank of New York Mellon's 13F filing for Q2 2023, filed 3 Aug 2023.